{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T19:26:08Z","timestamp":1788895568002,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012476","name":"Fundamental Research Funds for Central Universities of the Central South University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012476","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.phymed.2026.158034","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T20:35:28Z","timestamp":1772483728000},"page":"158034","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["High-throughput screened kaempferitrin potentiates trastuzumab efficacy in HER2-positive gastric cancer by targeting Cyclooxygenase-2 to inhibit ERK signaling"],"prefix":"10.1016","volume":"154","author":[{"given":"Huiming","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jumei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haotian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qichen","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lele","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wengui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1942-0905","authenticated-orcid":false,"given":"Zuoyi","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2026.158034_bib0001","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-40160-2","article-title":"Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management","volume":"13","author":"Agu","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2026.158034_bib0002","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jep.2012.11.016","article-title":"kaempferitrin induces apoptosis via intrinsic pathway in HeLa cells and exerts antitumor effects","volume":"145","author":"Alonso-Castro","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phymed.2026.158034_bib0003","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1517\/13543784.2014.912631","article-title":"The challenge of targeted therapies for gastric cancer patients: the beginning of a long journey","volume":"23","author":"Aprile","year":"2014","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"10.1016\/j.phymed.2026.158034_bib0004","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.phymed.2026.158034_bib0005","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa1113216","article-title":"Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer","volume":"366","author":"Baselga","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phymed.2026.158034_bib0006","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ccr.2007.08.030","article-title":"A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer","volume":"12","author":"Berns","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.phymed.2026.158034_bib0007","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.phymed.2026.158034_bib0008","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48254-6","article-title":"Dual-responsive (pH\/temperature) Pluronic F-127 hydrogel drug delivery system for textile-based transdermal therapy","volume":"9","author":"Chatterjee","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2026.158034_bib0009","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3892\/or.2014.3550","article-title":"Baicalein reverses hypoxia-induced 5-FU resistance in gastric cancer AGS cells through suppression of glycolysis and the PTEN\/Akt\/HIF-1\u03b1 signaling pathway","volume":"33","author":"Chen","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.phymed.2026.158034_bib0010","article-title":"Piperine inhibits cell proliferation and induces apoptosis of Human gastric cancer cells by downregulating phosphatidylinositol 3-kinase (PI3K)\/akt pathway","volume":"26","author":"Chen","year":"2020","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.phymed.2026.158034_bib0011","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrm1962","article-title":"EGF-ERBB signalling: towards the systems level","volume":"7","author":"Citri","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.phymed.2026.158034_bib0012","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1158\/1078-0432.CCR-03-0463","article-title":"Phase II study of celecoxib and trastuzumab in metastatic breast cancer patients who have progressed after prior trastuzumab-based treatments","volume":"10","author":"Dang","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2026.158034_bib0013","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.devcel.2017.07.014","article-title":"A real-time biosensor for ERK activity reveals signaling dynamics during C. elegans cell fate specification","volume":"42","author":"de la Cova","year":"2017","journal-title":"Dev. Cell"},{"key":"10.1016\/j.phymed.2026.158034_bib0014","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jep.2009.04.024","article-title":"Antinociceptive and anti-inflammatory kaempferol glycosides from Sedum dendroideum","volume":"124","author":"De Melo","year":"2009","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phymed.2026.158034_bib0015","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.7150\/ijbs.41768","article-title":"Drp1-mediated mitochondrial fission contributes to baicalein-induced apoptosis and autophagy in lung cancer via activation of AMPK signaling pathway","volume":"16","author":"Deng","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.phymed.2026.158034_bib0016","doi-asserted-by":"crossref","first-page":"9513","DOI":"10.1111\/jcmm.16891","article-title":"Mechanism of piperine in affecting apoptosis and proliferation of gastric cancer cells via ROS-mitochondria-associated signalling pathway","volume":"25","author":"Guo","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.phymed.2026.158034_bib0017","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0140-6736(16)31891-8","article-title":"Breast cancer","volume":"389","author":"Harbeck","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.phymed.2026.158034_bib0018","doi-asserted-by":"crossref","first-page":"eabp8314","DOI":"10.1126\/sciadv.abp8314","article-title":"Memory of stochastic single-cell apoptotic signaling promotes chemoresistance in neuroblastoma","volume":"9","author":"Hastings","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.phymed.2026.158034_bib0019","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1055\/s-2006-959513","article-title":"Kaempferitrin from the leaves of Hedyotis verticillata and its biological activity","volume":"60","author":"Hamzah","year":"1994","journal-title":"Planta Med."},{"key":"10.1016\/j.phymed.2026.158034_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118235","article-title":"Exploration of the underlying mechanism of astragaloside III in attenuating immunosuppression via network pharmacology and vitro\/vivo pharmacological validation","volume":"330","author":"He","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phymed.2026.158034_bib0021","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-25098-x","article-title":"Synergistic anticancer effects of chrysin and trastuzumab in HER2-positive breast cancer cells","volume":"15","author":"Jafari","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2026.158034_bib0022","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41586-021-04161-3","article-title":"The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer","volume":"600","author":"Janjigian","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.phymed.2026.158034_bib0023","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13058-019-1127-y","article-title":"Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancer","volume":"21","author":"Kennedy","year":"2019","journal-title":"Breast. Cancer Res."},{"key":"10.1016\/j.phymed.2026.158034_bib0024","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1146\/annurev-biochem-060614-034402","article-title":"A structural perspective on the regulation of the epidermal growth factor receptor","volume":"84","author":"Kovacs","year":"2015","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.phymed.2026.158034_bib0025","doi-asserted-by":"crossref","first-page":"6275","DOI":"10.1158\/0008-5472.CAN-05-0216","article-title":"Prostaglandin E2 activates mitogen-activated protein kinase\/erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner","volume":"65","author":"Krysan","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2026.158034_bib0026","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.4014\/jmb.1501.01017","article-title":"Combined treatment of herbal mixture extract H9 with trastuzumab enhances anti-tumor growth effect","volume":"25","author":"Lee","year":"2015","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.phymed.2026.158034_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115933","article-title":"A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K\/AKT signaling pathway","volume":"303","author":"Lin","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phymed.2026.158034_bib0028","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.bbrc.2020.07.045","article-title":"Baicalein enhanced cisplatin sensitivity of gastric cancer cells by inducing cell apoptosis and autophagy via akt\/mTOR and Nrf2\/Keap 1 pathway","volume":"531","author":"Li","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phymed.2026.158034_bib0029","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12943-024-02213-6","article-title":"Tailoring traditional Chinese medicine in cancer therapy","volume":"24","author":"Li","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phymed.2026.158034_bib0030","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jep.2017.07.023","article-title":"Computational and experimental prediction of molecules involved in the anti-melanoma action of berberine","volume":"208","author":"Liu","year":"2017","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phymed.2026.158034_bib0031","article-title":"Traditional Chinese Medicine in the treatment of chronic atrophic gastritis, precancerous lesions and gastric cancer","volume":"337","author":"Liu","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phymed.2026.158034_bib0032","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ccell.2020.03.007","article-title":"Intratumor heterogeneity: the Rosetta stone of therapy resistance","volume":"37","author":"Marusyk","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.phymed.2026.158034_bib0033","first-page":"24","article-title":"Biological and therapeutic impact of intratumour heterogeneity","volume":"5","author":"McGranahan","year":"2015","journal-title":"Cancer Discov."},{"key":"10.1016\/j.phymed.2026.158034_bib0034","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.ejca.2010.05.003","article-title":"Trastuzumab in gastric cancer","volume":"46","author":"Okines","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.phymed.2026.158034_bib0035","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ccell.2018.09.010","article-title":"Actionable activating oncogenic ERBB2\/HER2 transmembrane and juxtamembrane domain mutations","volume":"34","author":"Pahuja","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.phymed.2026.158034_bib0036","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5582\/bst.2015.01019","article-title":"The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer","volume":"9","author":"Qi","year":"2015","journal-title":"Biosci. Trends."},{"key":"10.1016\/j.phymed.2026.158034_bib0037","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.cell.2014.04.039","article-title":"High-sensitivity measurements of multiple kinase activities in live single cells","volume":"157","author":"Regot","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.phymed.2026.158034_bib0038","article-title":"Targeting pathological ERK1\/2 signaling in cancer and beyond","author":"Schanbacher","year":"2025","journal-title":"Trends Mol Med. adv. online publ."},{"key":"10.1016\/j.phymed.2026.158034_bib0039","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1053\/j.gastro.2019.09.026","article-title":"Mouse models of Human gastric cancer subtypes with stomach-specific CreERT2-mediated pathway alterations","volume":"157","author":"Seidlitz","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phymed.2026.158034_bib0040","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/ten.teb.2021.0026","article-title":"Triblock copolymer bioinks in Hydrogel three-dimensional printing for regenerative medicine: a focus on pluronic F127","volume":"28","author":"Shamma","year":"2022","journal-title":"Tissue Eng. B Rev."},{"key":"10.1016\/j.phymed.2026.158034_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.117999","article-title":"Therapeutic potential of traditional Chinese medicine in the prevention and treatment of digestive inflammatory cancer transformation: portulaca oleracea L. as a promising drug","volume":"327","author":"Shao","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phymed.2026.158034_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153606","article-title":"Xiao-Chai-Hu-Tang ameliorates tumor growth in cancer comorbid depressive symptoms via modulating gut microbiota-mediated TLR4\/MyD88\/NF-\u03bab signaling pathway","volume":"88","author":"Shao","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2026.158034_bib0043","doi-asserted-by":"crossref","first-page":"942","DOI":"10.2174\/1389557520666200212104742","article-title":"Medicinal potential of heterocyclic compounds from diverse natural sources for the management of cancer","volume":"20","author":"Singh","year":"2020","journal-title":"Mini. Rev. Med. Chem."},{"key":"10.1016\/j.phymed.2026.158034_bib0044","doi-asserted-by":"crossref","first-page":"7142","DOI":"10.1073\/pnas.1016569108","article-title":"Anti-ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti-PD-1 or anti-CD137 mAb therapy","volume":"108","author":"Stagg","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phymed.2026.158034_bib0045","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/jpp\/rgad046","article-title":"kaempferitrin, a major compound from ethanol extract of Chenopodium ambrosioides, exerts antitumour and hepatoprotective effects in the mice model of human liver cancer xenografts","volume":"75","author":"Su","year":"2023","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.phymed.2026.158034_bib0046","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005063","article-title":"CD40\u00d7HER2 bispecific antibody overcomes the CCL2-induced trastuzumab resistance in HER2-positive gastric cancer","volume":"10","author":"Sun","year":"2022","journal-title":"J. ImmunOther Cancer"},{"key":"10.1016\/j.phymed.2026.158034_bib0047","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/S1470-2045(18)30481-9","article-title":"Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 study","volume":"19","author":"Tabernero","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.phymed.2026.158034_bib0048","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S1470-2045(17)30111-0","article-title":"Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2\/3 study","volume":"18","author":"Thuss-Patience","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.phymed.2026.158034_bib0049","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.semcancer.2021.05.010","article-title":"RAF-MEK-ERK pathway in cancer evolution and treatment","volume":"85","author":"Ullah","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.phymed.2026.158034_bib0050","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s10120-014-0402-y","article-title":"HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer","volume":"18","author":"Van Cutsem","year":"2015","journal-title":"Gastric. Cancer"},{"key":"10.1016\/j.phymed.2026.158034_bib0051","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1007\/s12272-014-0487-1","article-title":"Preliminary in vitro and ex vivo evaluation of afzelin, kaempferitrin and pterogynoside action over free radicals and reactive oxygen species","volume":"38","author":"Vellosa","year":"2015","journal-title":"Arch. Pharm. Res."},{"issue":"6","key":"10.1016\/j.phymed.2026.158034_bib0052","doi-asserted-by":"crossref","first-page":"e1702","DOI":"10.1038\/cddis.2015.69","article-title":"Induction of COX2-PGE2 synthesis by activation of the MAPK\/ERK pathway contributes to neuronal death triggered by TDP-43-depleted microglia","author":"Xia","year":"2015","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.phymed.2026.158034_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120266","article-title":"Berberine inhibits gastric cancer development and progression by regulating the JAK2\/STAT3 pathway and downregulating IL-6","volume":"290","author":"Xu","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.phymed.2026.158034_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153575","article-title":"Fuzheng Jiedu Xiaoji formulation inhibits hepatocellular carcinoma progression in patients by targeting the AKT\/CyclinD1\/p21\/p27 pathway","volume":"87","author":"Yang","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2026.158034_bib0055","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.cell.2015.08.015","article-title":"Cyclooxygenase-dependent tumor growth through evasion of immunity","volume":"162","author":"Zelenay","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.phymed.2026.158034_bib0056","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1172\/JCI32278","article-title":"ErbB receptors: from oncogenes to targeted cancer therapies","volume":"117","author":"Zhang","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phymed.2026.158034_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110245","article-title":"Berberine represses human gastric cancer cell growth in vitro and in vivo by inducing cytostatic autophagy via inhibition of MAPK\/mTOR\/p70S6K and Akt signaling pathways","volume":"128","author":"Zhang","year":"2020","journal-title":"Biomed. PharmacOther"},{"key":"10.1016\/j.phymed.2026.158034_bib0058","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cmet.2022.11.012","article-title":"Discovery of a potent allosteric activator of DGKQ that ameliorates obesity-induced insulin resistance via the sn-1,2-DAG-pkc\u03b5 signaling axis","volume":"35","author":"Zheng","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.phymed.2026.158034_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.108693","article-title":"Potential anti-liver cancer targets and mechanisms of kaempferitrin based on network pharmacology, molecular docking and experimental verification","volume":"178","author":"Zhou","year":"2024","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.phymed.2026.158034_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188549","article-title":"HER2-targeted therapies in gastric cancer","volume":"1876","author":"Zhu","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326002709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326002709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:51:02Z","timestamp":1777593062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711326002709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":60,"alternative-id":["S0944711326002709"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158034","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-throughput screened kaempferitrin potentiates trastuzumab efficacy in HER2-positive gastric cancer by targeting Cyclooxygenase-2 to inhibit ERK signaling","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"158034"}}